WO2003039459A3 - Viral vector production methods and compositions - Google Patents

Viral vector production methods and compositions Download PDF

Info

Publication number
WO2003039459A3
WO2003039459A3 PCT/US2002/035049 US0235049W WO03039459A3 WO 2003039459 A3 WO2003039459 A3 WO 2003039459A3 US 0235049 W US0235049 W US 0235049W WO 03039459 A3 WO03039459 A3 WO 03039459A3
Authority
WO
WIPO (PCT)
Prior art keywords
viral vector
compositions
production methods
vector production
provides methods
Prior art date
Application number
PCT/US2002/035049
Other languages
French (fr)
Other versions
WO2003039459A2 (en
Inventor
Lee-Cheng Liu
Perry Newton
Shoupeng Lai
Stephen Morris
Chad Atwell
Christon Hill
Megan Fitzpatrick
Sami Cardak
Alena Lizonova
Lu Qin
Miguel E Carrion
Brenk K Harris
Original Assignee
Genvec Inc
Lee-Cheng Liu
Perry Newton
Shoupeng Lai
Stephen Morris
Chad Atwell
Christon Hill
Megan Fitzpatrick
Sami Cardak
Alena Lizonova
Lu Qin
Miguel E Carrion
Brenk K Harris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genvec Inc, Lee-Cheng Liu, Perry Newton, Shoupeng Lai, Stephen Morris, Chad Atwell, Christon Hill, Megan Fitzpatrick, Sami Cardak, Alena Lizonova, Lu Qin, Miguel E Carrion, Brenk K Harris filed Critical Genvec Inc
Priority to AU2002348151A priority Critical patent/AU2002348151A1/en
Publication of WO2003039459A2 publication Critical patent/WO2003039459A2/en
Publication of WO2003039459A3 publication Critical patent/WO2003039459A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material

Abstract

The present invention provides methods of preparing viral vector particles and viral vector particle compositions.
PCT/US2002/035049 2001-11-05 2002-10-31 Viral vector production methods and compositions WO2003039459A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002348151A AU2002348151A1 (en) 2001-11-05 2002-10-31 Viral vector production methods and compositions

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US33287301P 2001-11-05 2001-11-05
US60/332,873 2001-11-05
US33212001P 2001-11-13 2001-11-13
US60/332,120 2001-11-13

Publications (2)

Publication Number Publication Date
WO2003039459A2 WO2003039459A2 (en) 2003-05-15
WO2003039459A3 true WO2003039459A3 (en) 2003-11-20

Family

ID=26988068

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/035049 WO2003039459A2 (en) 2001-11-05 2002-10-31 Viral vector production methods and compositions

Country Status (2)

Country Link
AU (1) AU2002348151A1 (en)
WO (1) WO2003039459A2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007016250A1 (en) * 2005-07-28 2007-02-08 Genvec, Inc. Method of purifying protein
DK2424991T3 (en) 2009-05-02 2018-09-17 Genzyme Corp Gene therapy for neurodegenerative diseases
SG182490A1 (en) * 2010-01-12 2012-08-30 Vascular Biogenics Ltd Methods of producing adenovirus vectors and viral preparations generated thereby
AU2012342355B2 (en) 2011-11-24 2017-10-12 Genethon Scalable lentiviral vector production system compatible with industrial pharmaceutical applications
KR102015933B1 (en) * 2012-04-08 2019-08-29 인벤트프라이즈 엘엘씨 Systems and methods of virus propagation in cell culture for vaccine manufacture
CN105143443A (en) * 2013-02-22 2015-12-09 建新公司 Microcarrier perfusion culturing methods and uses thereof
MX367025B (en) 2013-02-22 2019-08-02 Genzyme Corp Microcarrier perfusion culturing methods and uses thereof.
DK2970920T3 (en) * 2013-03-15 2018-08-06 Childrens Hospital Philadelphia SCALABLE MANUFACTURING PROCESS FOR MANUFACTURING RECOMBINANT LENTIVIRAL VECTORS IN SERUM-FREE SUSPENSION CELL CULTURE SYSTEM
CA2920191C (en) * 2013-07-18 2022-03-01 Children's Hospital Medical Center Methods of improving titer in transfection-based production systems using eukaryotic cells
EP3122866B1 (en) 2014-03-25 2019-11-20 Terumo BCT, Inc. Passive replacement of media
TWI743024B (en) 2014-06-06 2021-10-21 美商健臻公司 Perfusion culturing methods and uses thereof
TW202246486A (en) 2014-06-09 2022-12-01 美商健臻公司 Seed train processes and uses thereof
SG11201705103WA (en) 2014-12-22 2017-07-28 Genzyme Corp Methods of culturing a mammalian cell
EP3054007A1 (en) 2015-02-09 2016-08-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
WO2018128688A1 (en) * 2016-11-04 2018-07-12 Baxalta Incorporated Adeno-associated virus purification methods
US11702634B2 (en) 2017-03-31 2023-07-18 Terumo Bct, Inc. Expanding cells in a bioreactor
AU2018253088A1 (en) * 2017-04-10 2019-11-28 Epicentrx, Inc. Method for producing recombinant virus
US11603527B2 (en) * 2017-12-27 2023-03-14 Global Life Sciences Solutions Usa Llc Method and kit for viral vector isolation
CN110317832B (en) * 2018-03-28 2022-07-05 西比曼生物科技（香港）有限公司 GMP (good manufacturing practice) scale preparation method of purified preparation of recombinant lentiviral vector
CN110317791A (en) 2018-03-29 2019-10-11 西比曼生物科技（香港）有限公司 The method of GMP grades of serum free suspension cell large-scale production slow virus
CN114181970B (en) * 2020-09-15 2023-07-25 上海药明巨诺生物医药研发有限公司 Lentiviral vector purification method
WO2022087509A1 (en) * 2020-10-23 2022-04-28 Ology Bioservices, Inc. Method for infecting cells with virus

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143548A (en) * 1995-08-30 2000-11-07 Genzyme Corporation Chromatographic purification of adeno-associated virus (AAV)
US6168941B1 (en) * 2000-04-07 2001-01-02 Genvec, Inc. Method of producing adenoviral vector stocks
US6194191B1 (en) * 1996-11-20 2001-02-27 Introgen Therapeutics, Inc. Method for the production and purification of adenoviral vectors
US6303362B1 (en) * 1998-11-19 2001-10-16 The Board Of Trustees Of The Leland Stanford Junior University Adenoviral vector and methods for making and using the same
US20010036657A1 (en) * 1996-12-13 2001-11-01 Tang John Chu-Tay Methods for purifying viruses

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143548A (en) * 1995-08-30 2000-11-07 Genzyme Corporation Chromatographic purification of adeno-associated virus (AAV)
US6194191B1 (en) * 1996-11-20 2001-02-27 Introgen Therapeutics, Inc. Method for the production and purification of adenoviral vectors
US20010036657A1 (en) * 1996-12-13 2001-11-01 Tang John Chu-Tay Methods for purifying viruses
US6303362B1 (en) * 1998-11-19 2001-10-16 The Board Of Trustees Of The Leland Stanford Junior University Adenoviral vector and methods for making and using the same
US6168941B1 (en) * 2000-04-07 2001-01-02 Genvec, Inc. Method of producing adenoviral vector stocks

Also Published As

Publication number Publication date
AU2002348151A1 (en) 2003-05-19
WO2003039459A2 (en) 2003-05-15

Similar Documents

Publication Publication Date Title
WO2003039459A3 (en) Viral vector production methods and compositions
IL159475A0 (en) Spherical protein particles, compositions containing the same and methods for the production thereof
AU2002321872A1 (en) Abrasive particles, and methods of making and using the same
AU2002319749A1 (en) Ceramic materials, abrasive particles, abrasive articles, and methods of making and using the same
AU2001238426A1 (en) Prepaints and methods of preparing paints from the prepaints
IL162228A0 (en) Shaped nanocrystal particles and methods for making the same
AU2002255719A1 (en) Method for manufacture of fine particles
WO2003027003A3 (en) Methods of nanotube films and articles
AU2003277103A1 (en) Creamer compositions and methods of making and using the same
EP1439017B8 (en) Monodisperse spherical metal particles
AU2003263024A1 (en) Process of forming and modifying particles and compositions produced thereby
AU2002307448A1 (en) Methods and compositions for the modulation of biofilm formation
AU2001291627A1 (en) Sustained release particle dispersion
WO2004062571A3 (en) Substantially pure cilostazol and processes for making same
NO20040944L (en) Process for the preparation of reduced average size silicon metal particles.
AU2002362761A1 (en) Generation of virus-like particles by vsv
WO2002102324A3 (en) Anti-arthropod vector vaccines methods of selecting and uses thereof
AU2003265265A1 (en) Process for coating ceramic particles and compositions formed from the same
WO2003039388A3 (en) Composite abrasive material for oral compositions, and methods of making and using same
EP1422258B8 (en) Polytetrafluoroethylene fine powder, polytetrafluoroethylene formed article prepared from the same and method for preparation of the same
AU2003296126A1 (en) Highly dispersible, fine, hydrophobic silica powder and process for producing the same
AU2002359792A1 (en) Methods and compositions for the inhibition of viral release
AU2002221276A1 (en) Insulator of particles created between the articulating components of artificialjoints
AU2001234687A1 (en) Fused -al2o3-mgo-y2o3 eutectic abrasive particles, abrasive articles, and methods of making and using the same
AU2002325494A1 (en) Polytetrafluoroethylene fine powder, polytetrafluoroethylene formed article prepared from the same and method for preparation of the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP